BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 18819824)

  • 21. Sleeping with the hypothalamus: emerging therapeutic targets for sleep disorders.
    Mignot E; Taheri S; Nishino S
    Nat Neurosci; 2002 Nov; 5 Suppl():1071-5. PubMed ID: 12403989
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Hypocretins, peptides associated with narcolepsy].
    Murillo-Rodríguez E; Arias-Carrión O
    Gac Med Mex; 2007; 143(5):421-5. PubMed ID: 18246936
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypocretins (orexins) and sleep-wake disorders.
    Baumann CR; Bassetti CL
    Lancet Neurol; 2005 Oct; 4(10):673-82. PubMed ID: 16168936
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The dual role of the orexin/hypocretin system in modulating wakefulness and respiratory drive.
    Gestreau C; Bévengut M; Dutschmann M
    Curr Opin Pulm Med; 2008 Nov; 14(6):512-8. PubMed ID: 18812827
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasticity in neurons synthesizing wake/arousal promoting hormone hypocretin/orexin.
    Gao XB
    Vitam Horm; 2012; 89():35-59. PubMed ID: 22640607
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The neurobiology, diagnosis, and treatment of narcolepsy.
    Scammell TE
    Ann Neurol; 2003 Feb; 53(2):154-66. PubMed ID: 12557281
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overview of orexin/hypocretin system.
    Mieda M; Sakurai T
    Prog Brain Res; 2012; 198():5-14. PubMed ID: 22813966
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A decade of hypocretin/orexin: accomplishments in sleep medicine.
    Thannickal TC
    Sleep Med Rev; 2009 Feb; 13(1):5-8. PubMed ID: 19059795
    [No Abstract]   [Full Text] [Related]  

  • 29. Narcolepsy: pathophysiology and pharmacology.
    Nishino S
    J Clin Psychiatry; 2007; 68 Suppl 13():9-15. PubMed ID: 18078360
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The hypothalamic peptidergic system, hypocretin/orexin and vigilance control.
    Nishino S
    Neuropeptides; 2007 Jun; 41(3):117-33. PubMed ID: 17376528
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship between CSF hypocretin levels and hypocretin neuronal loss.
    Gerashchenko D; Murillo-Rodriguez E; Lin L; Xu M; Hallett L; Nishino S; Mignot E; Shiromani PJ
    Exp Neurol; 2003 Dec; 184(2):1010-6. PubMed ID: 14769395
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CSF orexin-A/hypocretin-1 concentrations in patients with intracerebral hemorrhage (ICH).
    Dohi K; Ripley B; Fujiki N; Ohtaki H; Yamamoto T; Goto Y; Nakamachi T; Shioda S; Aruga T; Nishino S
    Regul Pept; 2008 Jan; 145(1-3):60-4. PubMed ID: 17868933
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Input of orexin/hypocretin neurons revealed by a genetically encoded tracer in mice.
    Sakurai T; Nagata R; Yamanaka A; Kawamura H; Tsujino N; Muraki Y; Kageyama H; Kunita S; Takahashi S; Goto K; Koyama Y; Shioda S; Yanagisawa M
    Neuron; 2005 Apr; 46(2):297-308. PubMed ID: 15848807
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypocretin (orexin) loss in Alzheimer's disease.
    Fronczek R; van Geest S; Frölich M; Overeem S; Roelandse FW; Lammers GJ; Swaab DF
    Neurobiol Aging; 2012 Aug; 33(8):1642-50. PubMed ID: 21546124
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Input organization and plasticity of hypocretin neurons: possible clues to obesity's association with insomnia.
    Horvath TL; Gao XB
    Cell Metab; 2005 Apr; 1(4):279-86. PubMed ID: 16054072
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Orexin/hypocretin plays a role in the response to physiological disequilibrium.
    Sinton CM
    Sleep Med Rev; 2011 Jun; 15(3):197-207. PubMed ID: 21269851
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activity-dependent release of adenosine inhibits the glutamatergic synaptic transmission and plasticity in the hypothalamic hypocretin/orexin neurons.
    Xia J; Chen F; Ye J; Yan J; Wang H; Duan S; Hu Z
    Neuroscience; 2009 Sep; 162(4):980-8. PubMed ID: 19465088
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Narcolepsy with cataplexy].
    Dauvilliers Y; Arnulf I
    Rev Neurol (Paris); 2008; 164(8-9):634-45. PubMed ID: 18805301
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Narcolepsy: selective hypocretin (orexin) neuronal loss and multiple signaling deficiencies.
    Bassetti CL
    Neurology; 2005 Oct; 65(8):1152-3. PubMed ID: 16247037
    [No Abstract]   [Full Text] [Related]  

  • 40. Orexin/hypocretin: a neuropeptide at the interface of sleep, energy homeostasis, and reward system.
    Tsujino N; Sakurai T
    Pharmacol Rev; 2009 Jun; 61(2):162-76. PubMed ID: 19549926
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.